Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status  Phase of research How it helps Latest publication
Sciadopitysin
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Thapsigargin
Potential treatment - pre-clinical evidence Natural product Other treatment Feb/03/2021
Ginkgo biloba leaves extract
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
L-Carnitine
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/14/2021
Ginkgolic acid C17:1
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Indole-3-carbinol
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/24/2021
Sargassum horneri polysaccharide extract
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/15/2021
Lactoferrin
Potential treatment - pre-clinical evidence Natural product Antiviral Jan/23/2021
(-)-Gallocatechin gallate
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/09/2021
Dihydromyricetin
Potential treatment - pre-clinical evidence Natural product Antiviral Jan/04/2021
Ipomoeassin F
Potential treatment - pre-clinical evidence Natural product Antiviral Jan/19/2021
Bromelain
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/06/2021
WiNeWsE
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/11/2021
Withanone
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/11/2021
Castanospermine
Potential treatment - pre-clinical evidence Natural product Antiviral Nov/16/2020
Protoporphyrin IX
Potential treatment - pre-clinical evidence Natural product Antiviral Dec/09/2020
Mentha haplocalyx extract
Potential treatment - pre-clinical evidence Natural product Antiviral Jan/15/2021
Ganoderma lucidum extract fraction RF3
Potential treatment - pre-clinical evidence Natural product Antiviral Jan/15/2021
Perilla frutescens extract
Potential treatment - pre-clinical evidence Natural product Antiviral Jan/15/2021
Lycorine
Potential treatment - pre-clinical evidence Natural product Antiviral Dec/16/2020